Single Royalty; Non-Royalty Sales. No royalty shall be payable under Section 3.4.1 above with respect to sales of the Licensed Product among GSK, its Affiliates and sublicensees for resale to a Third Party. In no event shall more than one such royalty be due Unigene hereunder with respect to the sale of each Licensed Product, even if such Licensed Product is covered by more than one Valid Claim within the Unigene Formulation Patent Rights.
Appears in 3 contracts
Samples: License Agreement (Unigene Laboratories Inc), License Agreement (Unigene Laboratories Inc), License Agreement (Unigene Laboratories Inc)
Single Royalty; Non-Royalty Sales. No royalty shall be payable under Section 3.4.1 3.3.1 above with respect to sales of the Licensed Product among GSK, its Affiliates and sublicensees for resale to a Third Party. In no event shall more than one such royalty be due Unigene Flamel hereunder with respect to the sale of each Licensed Product, even if such Licensed Product is covered by more than one Valid Claim within the Unigene Formulation Patent RightsClaim.
Appears in 2 contracts
Samples: License Agreement (Flamel Technologies Sa), License Agreement (Flamel Technologies Sa)
Single Royalty; Non-Royalty Sales. No royalty shall be payable --------------------------------- under Section 3.4.1 above with respect to sales of the Licensed Product among GSK, its Affiliates and sublicensees for resale to a Third Party. In no event shall more than one such royalty be due Unigene hereunder with respect to the sale of each Licensed Product, even if such Licensed ** Certain information on this page has been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the omitted portions. Product is covered by more than one Valid Claim within the Unigene Formulation Patent Rights.
Appears in 1 contract